Ethyl 2,2-difluoro-2-(2-oxo-2H-chromen-3-yl) acetate attenuates the malignant biological behaviors of non-small cell lung cancer via suppressing EGFR/PI3K/AKT/mTOR signaling pathway.
Liyi ZouXiaodan LiJiansuo LinXuehong FangJie LinLu ZhangYan ZhangYanwen LiangJianwei RenYi LiuZunnan HuangPublished in: The Journal of pharmacy and pharmacology (2024)
C2F inhibits malignant biological behaviors of NSCLC by suppressing EGFR/PI3K/AKT/mTOR signaling pathway.